tiprankstipranks
Selecta eligible for up to $615M in remaining  SEL-212 payments, royalties
PremiumThe FlySelecta eligible for up to $615M in remaining SEL-212 payments, royalties
6M ago
Selecta in pact to shift ImmTOR for SEL-212 rights and clinical ops to Sobi
PremiumThe Fly
Selecta in pact to shift ImmTOR for SEL-212 rights and clinical ops to Sobi
6M ago
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
PremiumPress Releases
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
6M ago
Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
PremiumPress ReleasesSelecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
8M ago
Selecta Biosciences expects cash to fund operations into 2027
PremiumThe Fly
Selecta Biosciences expects cash to fund operations into 2027
8M ago
Selecta Biosciences reports Q2 EPS (7c), consensus (8c)
PremiumThe Fly
Selecta Biosciences reports Q2 EPS (7c), consensus (8c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100